at a titer of 14 g/L, surpassing continuous gas fermentation without biomass retention and on par with glucose fermentation by T. kivui in chemostats. Coulombic efficiencies reached 80 %-90 % and energy efficiencies up to 30 % for acetate and methane production. The performance of this plate reactor demonstrates that MES can deliver production rates that are competitive with those of established biotechnologies.
No takes yet. Share an insight, caveat, or question.
Deutzmann et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: